1. Lacy, BE, Mearin, F, Chang, L, et al. Bowel disorders. Gastroenterology 2016; 150: 1393–1407.
Google Scholar | Crossref | ISI2. Lovell, RM, Ford, AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712–721.
Google Scholar | Crossref | Medline | ISI3. Saito, YA, Schoenfeld, P, Locke, GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910–1915.
Google Scholar | Medline | ISI4. Chang, FY, Lu, CL, Chen, TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil 2010; 16: 389–400.
Google Scholar | Crossref | Medline5. Ho, KY, Kang, JY, Seow, A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816–1822.
Google Scholar | Crossref | Medline6. Gwee, K-A, Wee, S, Wong, M-L, et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004; 99: 924–931.
Google Scholar | Crossref | Medline | ISI7. Siah, KTH, Wong, RK, Chan, YH, et al. Prevalence of irritable bowel syndrome in Singapore and its association with dietary, lifestyle, and environmental factors. J Neurogastroenterol Motil 2016; 22: 670–676.
Google Scholar | Crossref | Medline8. El-Serag, HB, Olden, K, Bjorkman, D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002; 16: 1171–1185.
Google Scholar | Crossref | Medline9. Wang, YT, Lim, HY, Tai, D, et al. The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective. BMC Gastroenterol 2012; 12: 104.
Google Scholar | Crossref | Medline10. Gwee, KA, Bak, YT, Ghoshal, UC, et al. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1189–1205.
Google Scholar | Crossref | Medline | ISI11. Gibson, PR, Shepherd, SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252–258.
Google Scholar | Crossref | Medline | ISI12. Gibson, PR, Shepherd, SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol 2012; 107: 657–666.
Google Scholar | Crossref | Medline | ISI13. Whelan, K, Martin, LD, Staudacher, HM, et al. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018; 31: 239–255.
Google Scholar | Crossref | Medline14. Barrett, JS . Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutr Clin Pract 2013; 28: 300–306.
Google Scholar | Crossref | Medline15. Barrett, JS, Gearry, RB, Muir, JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31: 874–882.
Google Scholar | Medline | ISI16. Ong, DK, Mitchell, SB, Barrett, JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366–1373.
Google Scholar | Crossref | Medline | ISI17. Shepherd, SJ, Gibson, PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006; 106: 1631–1639.
Google Scholar | Crossref | Medline18. Shepherd, S, Parker, F, Muir, J, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765–771.
Google Scholar | Crossref | Medline | ISI19. Staudacher, HM, Whelan, K, Irving, PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011; 24: 487–495.
Google Scholar | Crossref | Medline | ISI20. Halmos, EP, Power, VA, Shepherd, SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67–75, e5.
Google Scholar | Crossref | Medline | ISI21. Staudacher, HM, Lomer, MCE, Anderson, JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510–1518.
Google Scholar | Crossref | Medline | ISI22. De Roest, RH, Dobbs, BR, Chapman, BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013; 67: 895–903.
Google Scholar | Crossref | Medline | ISI23. Nanayakkara, WS, Skidmore, PM, O’Brien, L, et al. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol 2016; 9: 131–142.
Google Scholar | Medline | ISI24. Gwee, KA, Gonlachanvit, S, Ghoshal, UC, et al. Second Asian consensus on irritable bowel syndrome. J Neurogastroenterol Motil 2019; 25: 343–362.
Google Scholar | Crossref | Medline25. Guy’s and St Thomas’s NHS Foundation Trust, King’s College London . Reducing Fermentable Carbohydrates the Low FODMAP Way. London, UK: Kings College London, 2012.
Google Scholar26. University Monash and Central Clinical School, Department of Gastroentorology . The Monash University Low FODMAP Diet Booklet. 6th ed.. Melbourne, Australia: Monash University, 2013.
Google Scholar27. Muir, JG, Shepherd, SJ, Rosella, O, et al. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007; 55: 6619–6627.
Google Scholar | Crossref | Medline | ISI28. Muir, JG, Rose, R, Rosella, O, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 2009; 57: 554–565.
Google Scholar | Crossref | Medline | ISI29. Svedlund, J, Sjodin, I, Dotevall, G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129–134.
Google Scholar | Crossref | Medline | ISI30. Gordon, S, Ameen, V, Bagby, B, et al. Validation of irritable bowel syndrome global improvement scale an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci 2003; 48: 1317–1323.
Google Scholar | Crossref | Medline | ISI31. Wiklund, IK, Fullerton, S, Hawkey, CJ, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003; 38: 947–954.
Google Scholar | Crossref | Medline32. Wong, Z, Mok, C-Z, Majid, HA, et al. Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome. JGH Open 2018; 2: 178–181.
Google Scholar | Crossref | Medline33. Patcharatrakul, T, Juntrapirat, A, Lakananurak, N, et al. Effect of structural individual low-fodmap dietary advice vs. brief advice on a commonly recommended diet on IBS symptoms and intestinal gas production. Nutrients 2019; 11: 1–12.
Google Scholar | Crossref34. Abhari, K, Saadati, S, Hosseini-Oskouiee, F, et al. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management? Eur J Nutr 2020; 59: 2111–2117.
Google Scholar | Crossref | Medline35. Chatterjee, S, Park, S, Low, K, et al. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007; 102: 837–841.
Google Scholar | Crossref | Medline | ISI36. Eswaran, SL, Chey, WD, Han-Markey, T, et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016; 111: 1824–1832.
Google Scholar | Crossref | Medline | ISI37. Francis, CY, Morris, J, Whorwell, PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395–402.
Google Scholar | Crossref | Medline | ISI38. Biesiekierski, JR, Peters, SL, Newnham, ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320–328, e3.
Google Scholar | Crossref | Medline | ISI39. Food and Drug Administration (FDA), Center for Drug Evaluation and Research, (CDER). Guidance for Industry Irritable Bowel Syndrome — Clinical Evaluation of Products for Treatment, 2012. Silver Spring, MD: U.S. Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research (CDER). https://www.fda.gov/media/78622/download (accessed 9 May 2020).
Google Scholar40. Böhn, L, Störsrud, S, Liljebo, T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015; 149: 1399–1407.
Google Scholar | Crossref | Medline | ISI41. Pedersen, N, Andersen, NN, Végh, Z, et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014; 20: 16215–16226.
Google Scholar | Crossref | Medline | ISI42. Iacovou, M, Tan, V, Muir, JG, et al. The low FODMAP diet and its application in East and Southeast Asia. J Neurogastroenterol Motil 2015; 21: 459–470.
Google Scholar | Crossref | Medline43. Hewawasam, SP, Iacovou, M, Muir, JG, et al. Dietary practices and FODMAPs in South Asia: applicability of the low FODMAP diet to patients with irritable bowel syndrome. J Gastroenterol Hepatol 2018; 33: 365–374.
Google Scholar | Crossref | Medline